Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens. [electronic resource]
Producer: 20160309Description: 67-76 p. digitalISSN:- 1873-4995
- Amino Acid Sequence
- Antigen Presentation
- Antigens -- chemistry
- Antigens, CD -- immunology
- CD4-Positive T-Lymphocytes -- immunology
- CD8-Positive T-Lymphocytes -- immunology
- Cancer Vaccines -- administration & dosage
- Carbohydrate Sequence
- Cell Adhesion Molecules -- immunology
- Cross-Priming
- Dendritic Cells -- immunology
- Drug Delivery Systems
- Glycoconjugates -- chemistry
- Glycosphingolipids -- chemistry
- Humans
- Langerhans Cells -- immunology
- Lectins, C-Type -- immunology
- Liposomes -- chemistry
- Mannose-Binding Lectins -- immunology
- Molecular Sequence Data
- Peptides -- chemistry
- Polysaccharides -- chemistry
- Receptors, Cell Surface -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.